FDA Brief

Company record

CelestaPro

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about CelestaPro.

Warning letters

  1. CelestaPro

    FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.

    High risk